Ad is loading...
JBAVX
Price
$29.04
Change
-$0.25 (-0.85%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

JBAVX vs RLEFX

Header iconJBAVX vs RLEFX Comparison
Open Charts JBAVX vs RLEFXBanner chart's image
JHancock Balanced R5
Price$29.04
Change-$0.25 (-0.85%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
JBAVX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JBAVX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBAVX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. JBAVX (5.53B). RLEFX pays higher dividends than JBAVX: RLEFX (2.42) vs JBAVX (1.62). JBAVX was incepted earlier than RLEFX: JBAVX (16 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. JBAVX (62.00). JBAVX has a lower initial minimum investment than RLEFX: JBAVX (0) vs RLEFX (250). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. JBAVX (18.81). JBAVX return over 5 years is better than : 46.53 vs. RLEFX (35.95).
JBAVXRLEFXJBAVX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years9 years-
Gain YTD12.00414.21184%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.53B236B2%
Annual Yield % from dividends1.622.4267%
Returns for 1 year18.8121.0989%
Returns for 3 years10.4210.9595%
Returns for 5 years46.5335.95129%
Returns for 10 years69.11N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology